GAMMA Investing’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27K Buy
179
+170
+1,889% +$2.36K ﹤0.01% 4056
2026
Q2
$221 Sell
9
-28
-76% -$506 ﹤0.01% 4082
2026
Q1
$647 Buy
+37
New +$713 ﹤0.01% 3910

Other funds holding BIOA

GAMMA Investing's BIOA Position: Q3 2026 in Review

GAMMA Investing increased its BioAge Labs (BIOA) stake by 1,889% in Q3 2026, buying an estimated $2.36K and bringing the position to 179 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

GAMMA Investing first reported a position in BIOA in Q1 2026 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • GAMMA Investing held 179 shares of BioAge Labs worth $1.27K as of Q3 2026.
  • GAMMA Investing bought 170 BioAge Labs shares in Q3 2026, an estimated $2.36K.
  • BioAge Labs made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4056 holding.
  • GAMMA Investing first reported a position in BioAge Labs in Q1 2026 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.